Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.770
-0.050 (-2.75%)
At close: May 13, 2026, 4:00 PM EDT
1.700
-0.070 (-3.95%)
After-hours: May 13, 2026, 5:46 PM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $99.86 million as of May 13, 2026. Its market cap has decreased by -14.77% in one year.
Market Cap
99.86M
Enterprise Value
-62.38M
1-Year Change
-14.77%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $99.86M, a decrease of -96.95%. That is a compound annual growth rate of -47.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 102.69M | -0.25% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 109.90M |
| Rani Therapeutics Holdings | 109.79M |
| Cibus | 109.08M |
| Cognition Therapeutics | 105.44M |
| Oncolytics Biotech | 104.90M |
| Aldeyra Therapeutics | 103.15M |
| Coya Therapeutics | 100.63M |
| Anixa Biosciences | 98.91M |